Cel­gene, Ver­sant back a biotech merg­er, build­ing an an­ti­body pipeline and lin­ing up for the clin­ic

Ver­sant Ven­tures and Cel­gene have ex­tend­ed their deal to fos­ter a Toron­to-based biotech called North­ern Bi­o­log­ics, bring­ing in a Phase I-ready can­cer drug through a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.